Assessing the Willingness of Future Health Care Providers to Participate in Vaccine Trials: Cross-Sectional VACCELERATE European Study

Andreas Yiallouris   ¹ ;   Charalampos Filippou   ¹ ;   Christina Merakou   ¹ ;   Christos D Argyropoulos   ² ;   Sophia C Themistocleous   ¹ ;   George Shiamakkides   ¹ ;   Andreas Sarantopoulos   ¹ ;   Ahmed Razi Shaikh   ¹ ;   Evgenia Noula   ¹ ;   Andria Nearchou   ¹ ;   Elizabeth O Johnson   ¹ ;   Maria Papaconstantinou-Leontidou   ¹ ;   Charis Armeftis   ¹ ;   George Astras   ¹ ;   Fiona A Stewart   ^{3, 4} ;   Kerstin Albus   ^{3, 4} ;   Jon Salmanton-García   ^{3, 4} ;   Janina Leckler   ^{3, 4} ;   Anna Maria Azzini   ⁵ ;   Ruth Joanna Davis   ⁵ ;   Lenka Součková   ⁶ ;   Helena H Askling   ⁷ ;   Tobias Lindström Battle   ⁸ ;   Elena Álvarez-Barco   ⁹ ;   Augustina Mozeryte   ¹⁰ ;   Dimitrios Poulimeneas   ¹¹ ;   Ioannis Kopsidas   ¹¹ ;   Jana Baranda Prellezo   ^{12, 13} ;   Olena Valdenmaiier   ¹⁴ ;   Stine F Jakobsen   ¹⁴ ;   Rebecca Jane Cox   ¹⁵ ;   Margot Hellemans   ¹⁶ ;   Greet Hendrickx   ¹⁶ ;   Pierre van Damme   ¹⁶ ;   Jordi Ochando   ¹³ ;   Theoklis E Zaoutis   ¹¹ ;   Ligita Jancoriene   ¹⁰ ;   Patrick Mallon   ⁹ ;   Pontus Nauclér   ⁷ ;   Petr Husa   ⁶ ;   Evelina Tacconelli   ⁵ ;   Oliver A Cornely   ^{3, 4, 17, 18} ;   Zoi-Dorothea Pana   ¹⁹

¹ Department of Medicine, School of Medicine, European University Cyprus, Nicosia, Cyprus

² Department of Chemical Engineering, College of Chemicals and Materials, King Fahd University of Petroleum and Minerals, Dhahran, Saudi Arabia

³ Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany

⁴ Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany

⁵ Department of Diagnostic and Public Health, Infectious Diseases, University of Verona, Verona, Italy

⁶ Department of Pharmacology, University Hospital Brno, Masaryk University, Brno, Czech Republic

⁷ Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden

⁸ Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden

⁹ Centre for Experimental Pathogen Host Research, School of Medicine, University College Dublin, Dublin, Ireland

¹⁰ Department of Radiology, Nuclear Medicine and Medical Physics, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University Medical Faculty, Vilnius University, Vilnius, Lithuania

¹¹ Collaborative Center for Clinical Epidemiology and Outcomes Research (CLEO), Athens, Greece

¹² National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain

¹³ Department of Pharmaceutical Sciences and of Health, Microbiology Section, Faculty of Pharmacy, Universidad San Pablo CEU, Madrid, Spain

¹⁴ Centre of Excellence for Health, Immunity and Infections, University of Copenhagen, Copenhagen, Denmark

¹⁵ Department of Clinical Science, Influenza Centre, Bergen Energi (Norway), Bergen, Norway

¹⁶ VAXINFECTIO, Centre of Evaluation of Vaccination, Faculty of Medicine and Health Science, University of Antwerp, Antwerp, Belgium

¹⁷ Partner Site Bonn Cologne, German Center for Infection Research, Cologne, Germany

¹⁸ Clinical Trials Centre Cologne (ZKS Köln), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany

¹⁹ Department of Basic and Clinical Sciences, School of Medicine, University of Nicosia, Nicosia, Cyprus